CCEL Q2 2023 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q2 2023 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$8M+1.8% YoY

Gross Profit

$6M72.4% margin

Operating Income

$1M13.2% margin

Net Income

$220,9762.8% margin

EPS (Diluted)

$0.03

QoQ Revenue Growth

-0.7%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$131,657

Stock-Based Comp.

$156,417

Balance Sheet

Total Assets

$69M

Total Liabilities

$70M

Stockholders' Equity

-$858,375

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$8M	+1.8%
Gross Profit	$6M	$5M	+3.6%
Operating Income	$1M	$1M	-13.9%
Net Income	$220,976	$634,719	-65.2%

Revenue Segments

Processing And Storage Fees

$8M98%

Public Banking

$163,8162%

Product

$27,1770%